1-5 of 5
Zhanli Liang
Close
Sort by
Journal Articles

Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Ling Huang, MD, Xinmiao Jiang, MD, Wenyu Li, PhD, Hanguo Guo, Xiaojuan Wei, Sichu Liu, MD, Feili Chen, Zhanli Liang
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-142364
Published: 2020
Journal Articles

Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population

Wenyu Li, MD PhD, Ling Huang, MD, Xinmiao Jiang, MD, Xiaojuan Wei, Hanguo Guo, Liu Sichu, MD, Chen Feili, MD, Zhanli Liang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5271.
https://doi.org/10.1182/blood-2019-129552
Published: 2019
Journal Articles

TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

Ling Huang, MD, Xinmiao Jiang, MD, Hanguo Guo, Liu Sichu, MD, Xiaojuan Wei, Chen Feili, MD, Zhanli Liang, Wenyu Li, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5224.
https://doi.org/10.1182/blood-2019-126541
Published: 2019
Journal Articles

Next Generation Sequencing Highlights the Role of Cell Cycle and Apoptosis Dysregulation and Hepatitis B Infection in Refractory Diffuse Large B Cell Lymphoma

Wenyu Li, PhD, Xinmiao Jiang, Hanguo Guo, Xiaojuan Wei, Feili Chen, Sichu Liu, MD, Ling Huang, MD, Zhanli Liang
Journal: Blood
Blood (2017) 130 (Supplement 1): 5131.
https://doi.org/10.1182/blood.V130.Suppl_1.5131.5131
Published: 2017
Journal Articles

Antiviral Efficacy Analysis of Telbivudine Concurrent with the First Cycle of Chemotherapy in HBsAg-Positive Lymphoma Patients

Wenyu Li, Doctor of MDcine, Ling Huang, Master of MDcine, Hanguo Guo, undergraduate, Xiaojuan Wei, undergraduate, Zhanli Liang, undergraduate
Journal: Blood
Blood (2014) 124 (21): 4437.
https://doi.org/10.1182/blood.V124.21.4437.4437
Published: 2014